Navigation Links
PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
Date:9/26/2007

SEATTLE, Sept. 26 /PRNewswire/ -- Today at the Clinton Global Initiative annual conference, PATH announced the introduction of a ground-breaking vaccine to eliminate epidemic meningitis in Burkina Faso.

The meningococcal conjugate vaccine, developed by the Meningitis Vaccine Project, a partnership between the World Health Organization and PATH and produced by Serum Institute of India Limited has been developed for serogroup A Neisseria meningitidis (meningococcus), the principal cause of meningitis epidemics in Africa for more than 100 years.

The Michael & Susan Dell Foundation is committing $4 million to the project that will vaccinate more than nine million people between the ages of 1 and 29 against meningitis.

The Meningitis Vaccine Project, a partnership between PATH and WHO, will continue to raise the remainder of the $14 million required to conduct the initial activities.

More than 700,000 cases of the disease have been reported in the past ten years alone. The disease is virtually unknown in the United States, yet causes devastating loss of life and permanent disability in Africa.

"The introduction of the vaccine in Burkina Faso will set the stage for the ultimate elimination of meningitis in sub-Saharan Africa. The support from the Dell Foundation and other funders to roll out this life-saving vaccine is most welcome," said Dr Marie-Paule Kieny, Director, WHO Initiative for Vaccine Research.

"Now that a meningitis vaccine has been developed, with licensure anticipated in late 2008, an end to this devastating but neglected disease is within our grasp," said PATH president Christopher J. Elias, MD, MPH. "This project is a critical first step to providing evidence that epidemic meningitis can be eliminated on a country by country basis."

"We are committed to supporting international organizations working on the ground to save lives, reduce disease, and break the cycle of poverty through proven, highly cost-effec
'/>"/>

SOURCE PATH
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Preserve Samples for RNA Expression Microarrays RNAlater Around the World
2. RNAlater Around the World: The Art of Processing Difficult Samples
3. The Worlds Best DNase Improved TURBO DNA-free
4. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
5. The Right Brain: A neurological solution to the flattening world
6. Northwestern Mutual, American Family make Computerworlds best IT workplaces
7. MailFoundry claims worlds fastest anti-spam filter
8. Fusion 2007: Innovation drives productivity in post 24x7 world
9. Joining the wiki wacki world
10. The flattening world and its impact on U.S. biotech
11. The world of in-vitro diagnostics is another Midwest success story
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008)...srael, October 15 /-,Simbionix USA Co... a Series,C round of growth capital financing led ...t investor Early Stage Partners and other existing... who served as the,company,s investment bankers. T...the already rapid growth of its medical simulation...
(Date:10/15/2008)...ire-FirstCall/ -- Cryo-Cell,International, Inc. (O...he,world,s largest and most established family cor...rd quarter and nine months ended August 31,2008.,... approximately $4.5,million compared to approximat...e Company reported a net loss in the third quarter...
(Date:10/15/2008)...osition in Targeting Chemokine Receptor ...AIN VIEW, Calif., Oct. 15 /- ChemoCen...a Phase I clinical trial of CCX025,the company,s ...administered compound that inhibits the chemokine ... Traficet-EN(TM) (CCX282-B; ChemoCentryx,s CCR9,an...
(Date:10/15/2008)...ire/ -- SourceSolution, a leader in,search technol...tries,announced today that it is on target to lau... time and cost of screening contract manufacturing...ietary technology will be,offered to customers as ...ase will allow users to perform detailed searches ...
Breaking Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 3ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 4SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies 2
... Technology Network (WTN) just turned one! It is b...ee what we have accomplished in just 12 months of ...by Amazon and powered by Goggle) wistechnology.co... reach, and page views compared to other technolog...st. WTN is read beyond Wisconsin with 30% of its, ...
...over Spirit, which bounced to a near pinpoint land...Saturday (Jan. 3) after a seven-month flight, prom...Madison scientists say. , ,John Valley, a UW-Madis...ducted isotopic analyses of meteorites believed to...onsiderably to our knowledge of Mars and whether o...
...,Lets start with the good in Midwest biotech in 20...ormance of the publicly traded Midwest biotech com... Index, which evaluates the top 20 biotech stocks ...tellar performance of the Nasdaq and Amex Biotech ...lly ticked up even more in the last trading days o...
.... - GE Medical Systems and University Community H...ealth network based in Tampa, Florida have announc...dvanced heart hospitals. GE Medical Systems will...scular hospital, designed to deliver cardiovascula...hnology, when it opens in the spring of 2005. , ,...
Other Biology Technology:WTN's First Year 2The Good, Bad, Ugly of Midwest Biotech in 2003 2The Good, Bad, Ugly of Midwest Biotech in 2003 3GE Medical Enables Digital Heart Hospital 2GE Medical Enables Digital Heart Hospital 3
(Date:10/15/2008)..., Ulrike Gaul, professor of molecular biology at ... professor of theoretical physics at New York Univ...or the first Alexander von Humboldt professorships... (LMU) Mnchen nominated the two scientists for thi... by the Humboldt Foundation panel. This distinctio...
(Date:10/15/2008)..., Salk researcher Dr. Fred H. Gage, professor in ...eio Medical Science Prize for his discovery of the...lian brains. He will officially receive the award ...edicine in Japan on Nov. 21. , Dr. Gage,s labora...tem and unexpected plasticity and adaptability to ...
(Date:10/15/2008)..., Reston, VA (October 28, 2008) -- A study(1) pub...al, Toxicological Sciences, which is published b...cology, describes the kidney toxicity of melamine ...to characterize the toxicity of the compounds that...This research points to a possible link between th...
(Date:10/15/2008)..., As concerns about the effects of global warming...ecember issue of Physiological and Biochemical Zo...re of only two degrees Celsius could have a devast...kangaroos. , "Our study provides evidence that c...e range contractions, and the possible extinction ...
Breaking Biology News(10 mins):2 Alexander von Humboldt professorships go to LMU Munich 22 Alexander von Humboldt professorships go to LMU Munich 32 Alexander von Humboldt professorships go to LMU Munich 42 Alexander von Humboldt professorships go to LMU Munich 5Global warming threatens Australia's iconic kangaroos 2Study shows increased education on nanotech human enhancement increases public concerns 4070 1Study shows increased education on nanotech human enhancement increases public concerns 4070 2Assurant Health Names Jennifer Kopps Wagner Senior Vice President and General Counsel 24093 1Assurant Health Names Jennifer Kopps Wagner Senior Vice President and General Counsel 24093 2First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 1First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 2First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 3First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 4First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 5PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 1PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 2PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 3PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 4
...r all its promise, the prospect of using nanoparti...cts has raised concerns about possible harmful eff... University of Michigan are addressing those conce...icles damage cell membranes---enough to cause cell...revented. , "If you,re inventing these sorts of ma...
...ees in the world¹s most productive forests -- fore... tend to die young, according to a U.S. Geological...f the journal Ecology Letters. This discovery coul... to ongoing and future environmental changes. , "O...the world¹s most productive forests may be those l...
...ltiple sclerosis (MS) can be an unpredictable dise...acks healthy nerve cells and disrupts normal nerve...mptoms—including tingling, paralysis, pain, fatigu...y or in combination, sporadically or persistently....flare-ups are common in the majority of patients. ...
...number of articles explore the use of positron emi...onsurgical techniques that open the door to unders...issue of the Society of Nuclear Medicine,s Journal...nimal imaging "is the ability to carry out many st..." said SNM member Michael J. Welch, Ph.D., co-auth...
Other Biology News:Probing the promise and perils of nanoparticles 2Live fast, die young true for forests too 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4
Rad51B
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies.
Biology Products: